Joanna Plisiecka-Hałasa

Ovarian small cell carcinoma of hypercalcemic type – evidence of germline origin and smarca4 gene inactivation. a pilot study

Jolanta Kupryjańczyk, Agnieszka Dansonka‐Mieszkowska, Joanna Moes-Sosnowska et al. · Polish Journal of Pathology · 2013 · 115 citations · Full text

Immature Teratoma, Smarca4 Gene Inactivation, Pathology +18

P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens

Joanna Plisiecka-Hałasa, G Karpińska, T Szymańska et al. · Annals of Oncology · 2003 · 53 citations · Full text

Platinum-based Regimens, Ovarian Carcinomas, Medicine +9

TP53 status determines clinical significance of ERBB2 expression in ovarian cancer

Jolanta Kupryjańczyk, Radosław Mądry, Joanna Plisiecka-Hałasa et al. · British Journal of Cancer · 2004 · 38 citations · Full text

Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type

Joanna Moes-Sosnowska, Lukasz M. Szafron, Dorota Nowakowska et al. · Orphanet Journal of Rare Diseases · 2015 · 34 citations · Full text

Nijmegen breakage syndrome gene (<i>NBS1</i>) alterations and its protein (nibrin) expression in human ovarian tumours

Joanna Plisiecka-Hałasa, Agnieszka Dansonka‐Mieszkowska, Alina Rembiszewska et al. · Annals of Human Genetics · 2002 · 24 citations · Full text

Tumoral Pathology, Nibrin Expression, Nbs1 Gene Alterations +14